Levin Jennifer B, Krivenko Anna, Howland Molly, Schlachet Rebecca, Sajatovic Martha
Department of Psychiatry, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center, 10524 Euclid Avenue, Cleveland, OH, 44106, USA.
Neurological and Behavioral Outcomes Center, University Hospitals Case Medical Center, Cleveland, OH, 44106, USA.
CNS Drugs. 2016 Sep;30(9):819-35. doi: 10.1007/s40263-016-0368-x.
Poor medication adherence is a pervasive problem that causes disability and suffering as well as extensive financial costs among individuals with bipolar disorder (BD). Barriers to adherence are numerous and cross multiple levels, including factors related to bipolar pathology and those unique to an individual's circumstances. External factors, including treatment setting, healthcare system, and broader health policies, can also affect medication adherence in people with BD. Fortunately, advances in research have suggested avenues for improving adherence. A comprehensive review of adherence-enhancement interventions for the years 2005-2015 is included. Specific bipolar adherence-enhancement approaches that target knowledge gaps, cognitive patterns, specific barriers, and motivation may be helpful, as may approaches that capitalize on technology or novel drug-delivery systems. However, much work remains to optimally facilitate long-term medication adherence in people with BD. For adherence-enhancement approaches to be widely adapted, they need to be easily accessible, affordable, and practical.
药物治疗依从性差是一个普遍存在的问题,它会导致双相情感障碍(BD)患者出现残疾、痛苦,还会产生巨额经济成本。依从性的障碍众多且涉及多个层面,包括与双相情感障碍病理相关的因素以及个体情况所特有的因素。外部因素,包括治疗环境、医疗保健系统和更广泛的健康政策,也会影响双相情感障碍患者的药物治疗依从性。幸运的是,研究进展已提出了改善依从性的途径。本文纳入了对2005年至2015年依从性增强干预措施的全面综述。针对知识差距、认知模式、特定障碍和动机的特定双相情感障碍依从性增强方法可能会有所帮助,利用技术或新型药物递送系统的方法也可能如此。然而,要最佳地促进双相情感障碍患者的长期药物治疗依从性,仍有许多工作要做。为了使依从性增强方法得到广泛应用,它们需要易于获取、价格合理且切实可行。